Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: Results in nine patients from a single institution

Bone Marrow Transplantation

Volumn 27, Issue 7, 2001, Pages 693-701

  Sanz, G F ^a   Saavedra, S ^a   Jimenez C ^c   Senent, L ^a   Cervera, J ^a   Planelles, D ^b   Bolufer, P ^a   Larrea, L ^b   Martin G ^a   Martinez J ^a   Jarque, I ^a   Moscardo F ^a   Plume G ^c   Andreu, R ^c   De La Rubia, J ^c   Barragan E ^a   Solves, P ^b   Soler, M A ^b   Sanz, M A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Centro de Transfusion de la Comunidad Valenciana   (Spain)

^c NONE

Author keywords

Chronic myelogenous leukemia; Cord blood transplantation; Hematopoietic stem cell transplantation; Unrelated donor

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; BUSULFAN; CHLORPHENIRAMINE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUCONAZOLE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 1; HYDROXYUREA; IDARUBICIN; IMMUNOGLOBULIN; LYMPHOGLOBULINE; METHYLPREDNISOLONE; PARACETAMOL; PREDNISONE; THIOTEPA; THYMOCYTE ANTIBODY;

ADULT; AGE; ARTICLE; AUTOTRANSPLANTATION; BLAST CELL CRISIS; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER REGRESSION; CELL COUNT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DISEASE SEVERITY; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFUSION; MALE; NEUTROPHIL; PRIORITY JOURNAL; RELATIVE; SEROLOGY; SURVIVAL; THROMBOCYTE; TIME; UMBILICAL CORD BLOOD;

ACUTE DISEASE; ADULT; BLOOD DONORS; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; FETAL BLOOD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; PILOT PROJECTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 17744369066     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702878     Document Type: Article

References (41)

1. Interferon alpha versus chemotherapy for chronic myeloid leukemia: A meta-analysis of seven randomized trials
2. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
3. Conversion of interferon-induced, long-term cytogenetic remissions in chronic myelogenous leukemia to polymerase chain reaction negativity
4. Clinical efficacy and safety of an ABL specific tyrosine kinase inhibitor as targeted therapy for chronic myelogenous leukemia
5. Lessons learned from the development of an ABL tyrosine kinase inhibitor for chronic myeloid leukemia
6. Marrow transplantation for the treatment of chronic myelogenous leukemia
7. Bone marrow transplantation for patients with chronic myeloid leukemia
8. Chronic myeloid leukemia
9. Chronic myelogenous leukemia: Biology and therapy
10. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
11. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program
12. Placental blood as source of hematopoietic stem cells for transplantation into unrelated recipients
13. Outcome of cord blood transplantation from related and unrelated donors
14. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord-blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease
15. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation
16. Outcome among 562 recipients of placental blood transplants from unrelated donors
17. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling
18. Comparison of the outcome of unrelated bone marrow (BM) or cord blood (CB) transplants in children with acute leukemia (AL)
19. Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia
20. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood
21. Unrelated umbilical cord blood transplants in adult patients (PTS) with hematological malignancies or genetic disorders
22. Microdroplet assay of human serum cytoxins
23. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation
24. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization
25. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution
26. A simple salting out procedure for extracting DNA from human nucleated cells
27. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: Application to the apolipoprotein B 3′ hypervariable region
28. Analysis of the VNTR locus D1S80 by PCR followed by high resolution PAGE
29. Rapid PCR analysis of the St14 (DXS52) VNTR
30. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
31. Minimal residual disease after allogenic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: Correlations with acute graft-versus-host disease and relapse
32. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling
33. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease
34. Unrelated mismatched cord blood transplantation in an adult with secondary AML
35. Umbilical cord blood transplantation from an unrelated donor in an adult weighing 90 kilograms. Role of immunosuppression in engraftment
36. Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia
37. Successful salvage using mismatched umbilical cord blood transplant in an adult with recurrent acute myelogenous leukemia failing autologous peripheral blood progenitor cell transplant: A case history and review
38. Prognostic factors of outcome after unrelated cord blood transplant (UCBT) in adults with hematologic malignancies
39. Hematopoietic recovery in adult recipients following unrelated umbilical cord blood transplantation
40. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: Graft progenitor cell content is a better predictor than nucleated cell quantity
41. Factors associated with outcome after cord blood transplantation in children with acute leukemia